Coconut Oil and MCT Oil: Benefits, Forms, Dosing, and Side Effects

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Medium chain triglycerides (MCTs) are a class of saturated fats composed of glycerol attached to fatty acids with carbon chains of 6 to 12 atoms in length. The three primary MCTs of nutritional interest are caprylic acid (C8, 8 carbons), capric acid (C10, 10 carbons), and lauric acid (C12, 12 carbons) [1]. Virgin ("cold pressed") coconut oil is the most widely consumed natural source of MCTs, containing approximately 62% MCTs by weight, although the majority of this is lauric acid [1][2]. The remaining composition includes long-chain triglycerides (LCTs) that give coconut oil its semi-solid consistency at room temperature [1].

The distinction between MCTs and LCTs is metabolically significant. During digestion, the shorter-chain MCTs — particularly caprylic and capric acids — are transported directly to the liver via the portal vein, bypassing the lymphatic system and the slower chylomicron-mediated absorption pathway used by long-chain fats [3][4]. This rapid hepatic delivery means MCTs are more readily oxidized for energy and are less likely to be deposited in adipose tissue compared to longer-chain fatty acids [1][3]. Caprylic and capric acids can also enter muscle cells quickly, providing a rapid fuel source [1]. In the liver, MCTs are efficiently converted to ketone bodies (beta-hydroxybutyrate and acetoacetate), which can serve as an alternative energy source for the brain and other tissues [4][5].

A critical nuance often overlooked in marketing is that lauric acid (C12), despite being technically classified as a medium-chain fatty acid, behaves metabolically more like a long-chain fatty acid in many respects [1][6]. A substantial portion of lauric acid is absorbed via the lymphatic pathway rather than direct portal transport, which means it does not share the rapid metabolism and ketone-generating properties of C8 and C10 to the same degree [1]. This distinction is important when evaluating products marketed as "MCT-rich" — virgin coconut oil, which is predominantly lauric acid, behaves very differently from refined MCT oil, which is predominantly caprylic and capric acids.

On a technical note, most of the weight (92% or more) of an MCT molecule comes from the fatty acids rather than the glycerol backbone. When laboratories analyze these oils, they typically hydrolyze them (break them apart) and measure the individual fatty acids, but product labels generally report the triglyceride values [1].

The MCTs in coconut oil are saturated fats. Unlike fats composed of longer-chain triglycerides that can be mono- or polyunsaturated (and may be more healthful from a cardiovascular perspective), MCTs and coconut oil are almost entirely saturated [1][7]. Coconut oil is approximately 82–92% saturated fat, and this percentage approaches 100% as the oil is further refined to pure MCT oil [7][8]. The American Heart Association (AHA) recommends limiting saturated fat intake to 5–6% of total daily calories — approximately 13 grams per day for an adult — and explicitly advises against routine use of coconut oil due to its potential to raise LDL cholesterol [7][9].

Despite these cardiovascular concerns, coconut oil and MCT oil have been promoted for a wide range of health benefits including weight loss, cognitive enhancement, improved athletic performance, blood sugar regulation, and skin health. This article examines the clinical evidence for each of these claims, the available forms and their differences, appropriate dosing, and the safety considerations that should guide decisions about incorporating these oils into diet or supplementation regimens.

Forms and Bioavailability

The term "coconut oil" encompasses several distinct products with markedly different compositions, and understanding these differences is essential for interpreting the clinical evidence and making informed choices.

Virgin and Extra-Virgin Coconut Oil

Virgin coconut oil (VCO) is obtained through minimal processing of fresh coconut meat, typically via wet milling or cold-pressing, which preserves the oil's natural coconut aroma, flavor, and bioactive compounds such as polyphenols and antioxidants [2][10]. The fatty acid profile of virgin coconut oil is approximately 45–52% lauric acid (C12), 16–21% myristic acid (C14), 7–10% palmitic acid (C16), 5–8% caprylic acid (C8), 5–7% capric acid (C10), and 5–10% oleic acid (C18:1), with small amounts of linoleic acid (1–2%) [2][8].

The total MCT content (C8 + C10 + C12) is approximately 62% of the oil, but the functionally significant MCTs — caprylic and capric acids, which are rapidly metabolized and ketogenic — constitute only about 10–15% of the total oil [1][2]. This means that a tablespoon (14 g) of virgin coconut oil provides only about 1.4–2.1 grams of the "fast-acting" C8 and C10 MCTs, with the remainder being lauric acid and long-chain fats that are metabolized more slowly.

Virgin coconut oil also retains higher levels of natural antioxidants compared to refined varieties, including total phenolics ranging from 10 to 50 mg gallic acid equivalents per 100 g and tocopherols (forms of vitamin E) [10]. These compounds may contribute to its antioxidant and anti-inflammatory properties when applied topically [10][11].

Testing by ConsumerLab found that virgin and "extra virgin" coconut oils are similar in chemical composition, so paying a premium for "extra virgin" labeling may not be worthwhile [1].

Refined Coconut Oil

Refined coconut oil is produced from copra (dried coconut kernel) and undergoes bleaching and deodorizing processes that remove much of the coconut flavor, aroma, and some bioactive compounds [2][12]. The refining process also removes much of the lauric acid and long-chain triglycerides, producing an oil that is liquid at room temperature and comprised mostly (85% or more) of caprylic and capric acids [1]. Refined coconut oil has a higher smoke point of approximately 204–232°C (400–450°F) compared to virgin coconut oil at 177°C (350°F), making it more suitable for high-heat cooking [12][13].

However, it should be noted that the dry-processed copra oil often requires further refining due to potential impurities from drying, and the refining process removes many of the polyphenols and antioxidants found in virgin coconut oil [2][12].

MCT Oil

MCT oil is further refined from coconut oil (or sometimes palm kernel oil) to contain 95% or more of caprylic and/or capric acid triglycerides [1]. This is the form most commonly used in clinical studies investigating cognitive benefits, weight loss, and ketone production, because it delivers the highest concentration of the rapidly metabolized MCTs without the diluting effect of lauric acid and long-chain fats [4][5].

MCT oil is a clear, odorless liquid at room temperature. For products marketed as MCT oil, the label should show that total MCTs comprise at least 95–100% of the serving, and ideally should specify the amounts of caprylic (C8) and capric (C10) acids [1]. Some products are marketed as "C8 only" MCT oil, containing primarily caprylic acid, which is the most ketogenic of the medium-chain fatty acids [5][14].

MCT Powder

MCT oil can be mixed with fibrous ingredients (typically acacia fiber, tapioca starch, or maltodextrin) and spray-dried to produce a powdered form [1]. MCT powders offer convenience for mixing into beverages and may cause fewer gastrointestinal side effects than liquid MCT oil due to the slower release of the oil from the fiber matrix [1]. However, the MCT content per serving is typically lower than liquid MCT oil because a significant portion of the weight comes from the carrier material.

Fractionated Coconut Oil

Fractionated coconut oil is produced by separating the medium-chain triglycerides from standard coconut oil, resulting in a clear, odorless liquid consisting primarily of caprylic (C8) and capric (C10) fatty acids [2]. This form is widely used in cosmetic and personal care products as a carrier oil due to its lightweight texture, stability, and resistance to rancidity [2]. It is functionally similar to MCT oil, though the term "fractionated coconut oil" is more commonly used in cosmetic contexts while "MCT oil" is used for dietary supplements.

Comparison Table

Form	MCT Content	Predominant Fatty Acids	State at Room Temp	Smoke Point	Primary Uses
Virgin Coconut Oil	~62% (mostly lauric)	Lauric (45–52%), Myristic (16–21%), C8 (5–8%), C10 (5–7%)	Semi-solid	177°C / 350°F	Cooking (low-medium heat), topical skin/hair, baking
Refined Coconut Oil	~85%+ (C8 + C10)	Caprylic and Capric acids predominantly	Liquid	204–232°C / 400–450°F	Cooking (higher heat), dietary supplement
MCT Oil	95–100% (C8 + C10)	Caprylic (C8) and/or Capric (C10)	Liquid	Not for cooking	Dietary supplement, ketogenic diets, cognitive support
MCT Powder	Variable (lower per serving)	C8 and C10 in carrier matrix	Powder	N/A	Beverages, convenience, those with GI sensitivity

Bioavailability Considerations

The bioavailability and metabolic fate of MCTs differ substantially from long-chain fatty acids. MCTs are absorbed directly into the portal circulation and transported to the liver without requiring bile salts or carnitine for mitochondrial entry, which allows for rapid oxidation and ketone body production [3][4]. This property makes MCTs particularly useful for individuals with conditions that impair fat absorption, such as pancreatic insufficiency, short bowel syndrome, and AIDS-related fat malabsorption [1][3].

The ketogenic potential of MCTs varies by chain length. Caprylic acid (C8) produces the most ketones per gram, followed by capric acid (C10), with lauric acid (C12) producing substantially fewer due to its partial absorption via the lymphatic route [4][5]. This is why clinical studies investigating cognitive benefits have predominantly used C8-rich or mixed C8/C10 MCT oils rather than virgin coconut oil.

Evidence for Benefits

Weight Loss and Body Composition

The rapid metabolism of MCTs has led to speculation that they may promote weight loss by increasing satiety, stimulating thermogenesis ("fat-burning"), and reducing fat deposition compared to long-chain fatty acids [1][3].

Positive evidence from controlled MCT studies. A study among 64 men and women in Japan found that those who consumed margarine containing 5 grams (about 1 teaspoon) of MCTs (caprylic and capric acids only) daily for three months while maintaining a diet of 2,100–2,400 kcal per day lost more body weight (9.3 lbs vs. 6.4 lbs) and more visceral fat (fat around the organs) than those on the same calorie-controlled diet who consumed margarine containing 5 grams of long-chain triglycerides (from vegetable oil) instead of MCTs (Nosaka et al., J Atheroscler Thromb, 2003) [15]. This study suggests that even modest amounts of MCTs, when substituted for long-chain fats in the diet, may support greater fat loss over time, particularly visceral fat.

In some clinical studies, a dose of 5 grams or more of MCTs has been found to increase satiety and thermogenesis compared to other types of fat (Clegg, Eur J Clin Nutr, 2017) [3]. The mechanism is thought to involve the rapid portal absorption of MCTs leading to earlier hepatic satiety signaling.

Negative evidence from coconut oil studies. However, studies using whole coconut oil rather than purified MCTs have generally failed to demonstrate meaningful weight loss benefits. A study of 29 obese men (average age 37) in Brazil on a calorie-controlled diet (2,500 calories per day) found that those who consumed one tablespoon (about 13.5 grams) of extra virgin coconut oil with dinner for 45 days did not lose more weight than those who consumed one tablespoon of soybean oil with dinner. Both groups had similar, slight decreases in body mass index (about −0.8 kg/m²) and waist circumference (about 1/3 of an inch). Those who consumed coconut oil had modest increases in HDL cholesterol compared to soybean oil (average increase of 3.67 mg/dL vs. a decrease of 3.79 mg/dL), although the cardiovascular significance of such a small HDL increase is uncertain (Vogel et al., Food Funct, 2020) [16].

Coconut oil does not reduce appetite more than other oils. A study among 29 overweight or obese adults (average age 70) showed that consuming a breakfast meal containing 50 grams of coconut oil was not more effective at reducing hunger or increasing satiety after the meal than consuming a meal containing similar calories and 50 grams of canola oil. Interestingly, meals containing less fat (25 grams of coconut or canola oil) were more effective at reducing hunger and increasing satiety after the meal than the high-fat meals, possibly because the lower-fat meals contained more fiber (about 11.2 grams vs. 6.6 grams) (Diekmann et al., J Nutr, 2025) [17].

Systematic review evidence. A 2025 systematic review and meta-analysis of clinical trials found no clinically significant effects of coconut oil supplementation on weight loss [18]. A separate 2024 systematic review similarly noted minimal impact on body weight from coconut oil supplementation, emphasizing that its high caloric density (approximately 120 calories per tablespoon) necessitates portion control to avoid exacerbating obesity [18].

Synthesis. The weight of the evidence suggests that purified MCTs (C8 and C10 specifically) may offer a modest advantage over long-chain fats when substituted in an isocaloric diet, primarily through increased thermogenesis and reduced visceral fat accumulation. However, virgin coconut oil, which is predominantly lauric acid and long-chain fats, does not appear to offer significant weight loss benefits compared to other vegetable oils. The calories from coconut oil still count, and overconsumption will lead to weight gain regardless of the fat type.

Cognitive Function and Alzheimer's Disease

Coconut oil and MCTs have been promoted as beneficial for Alzheimer's disease and cognitive decline based on the premise that a reduced uptake of glucose in the brain occurs in conditions associated with Alzheimer's risk — including aging (over 65), family history of Alzheimer's disease, and insulin resistance — and that ketone bodies produced from MCTs can provide an alternative fuel source for energy-starved brain cells [1][4][5].

Mild cognitive impairment (MCI) — the best evidence. The strongest clinical evidence comes from a two-phase, placebo-controlled study that found consuming a drink containing 30 grams of MCTs daily for 6 months (1) improved brain ketone metabolism (Fortier et al., Alzheimers Dement, 2019) [19] and (2) improved some measures of cognitive function in people with mild cognitive impairment. The clinical improvements were seen in measures of episodic memory, executive function, and language, and were associated with increased plasma ketone levels and brain ketone uptake. However, the improvements were small — for example, the number of words remembered on a free recall trial test (a measure of episodic memory) increased by one word out of 16 for the treatment group compared to 0.2 words for the placebo group. There was no improvement in measures of attention, and effects on processing speed were inconsistent (Fortier et al., Alzheimers Dement, 2020) [20].

The MCTs in this study consisted of 60% caprylic acid and 40% capric acid (Captex 355, Abitec Corp) blended with lactose-free milk. Half the drink was consumed with breakfast and the other half with dinner, and the amount consumed daily was gradually increased to 30 grams during the initial two weeks to minimize gastrointestinal side effects [19][20].

White matter energy supply. A follow-up analysis of data from the Fortier study showed that MCT supplementation improved energy supply to white matter (brain tissue made up of nerve fibers that deteriorate in MCI and Alzheimer's disease) by increasing ketone uptake 2.5- to 3.2-fold compared to placebo. The increase in energy supply directly correlated with improved processing speed, but not episodic memory, language, or executive function. The researchers speculated that increased ketone uptake may play a role in the structural integrity of myelin, the covering of nerve fibers in white matter that deteriorates in MCI. However, this was not confirmed (Roy et al., medRxiv, 2021 — preprint) [21]. It remains uncertain whether this product can slow the progression of MCI to Alzheimer's disease.

Industry-funded Alzheimer's studies. Two clinical studies funded by the maker of a "medical food" containing caprylic acid triglycerides (Axona, Accera) found that supplementation with MCTs increased ketone levels and improved certain measures of cognitive function in some individuals with probable or mild to moderate Alzheimer's disease (Henderson et al., Nutr Metab (Lond), 2009; Reger et al., Neurobiol Aging, 2004) [22][23]. The standard daily dose in these studies provided 20 to 40 grams of MCTs (95% of which was caprylic acid triglycerides). However, an FDA warning letter sent to Accera in 2013 noted that "there are no distinctive nutritional requirements or unique nutrient needs for individuals with mild to moderate Alzheimer's disease," and other experts emphasize there is not enough evidence to know whether ketones produced from consuming coconut oil or MCT oil have a beneficial effect in Alzheimer's disease (Fernando et al., Br J Nutr, 2015) [24].

Negative Alzheimer's studies. A study in Canada among 20 people (average age 73) with probable Alzheimer's disease found that taking, on average, about 1 tablespoon (15 mL) of MCT oil (Brain Octane by Bulletproof) twice daily for 4 months did not significantly improve cognitive outcome measures compared to placebo. Only after extending the study 7 months were improvements in measures of attention and psychomotor function found compared to placebo (olive oil). However, the lack of blinding during the latter 7 months limits the reliability of these results, and there were no between-group differences in other measures of cognitive function. The MCT oil contained 99.3% caprylic acid (C8), 0.6% capric acid (C10), and 0.1% lauric acid (C12). Side effects including vomiting, diarrhea, and abdominal cramping were reported by 64% of those taking MCT oil, particularly those taking the maximum daily dose (3 tablespoons) (Juby et al., TRCI, 2022) [14].

A study in Sri Lanka among 84 people with mild-to-moderate Alzheimer's disease showed that taking 15 mL (about 1 tablespoon) of virgin coconut oil twice daily (in the morning and evening, with or before a meal) for 6 months did not significantly improve cognition based on the mini-mental state examination (MMSE) or the executive clock drawing task compared to placebo (canola oil) (Fernando et al., J Alzheimers Dis, 2023) [25].

Recent systematic reviews. Post-2020 systematic reviews of coconut oil's role in brain health, particularly for Alzheimer's disease, indicate potential neuroprotective effects from MCTs via ketone provision as an alternative brain fuel, but clinical trials show no consistent improvements in cognitive function or disease progression [26].

Synthesis. The theoretical basis for MCTs supporting cognition — providing ketone-based alternative fuel to glucose-deprived brain cells — is plausible. However, the clinical evidence is mixed. MCT oil (not coconut oil) at 30 g/day showed small improvements in some cognitive measures in people with MCI after 6 months, but studies in established Alzheimer's disease have largely failed to demonstrate benefit. Virgin coconut oil, with its much lower C8/C10 content, showed no benefit for Alzheimer's disease. The evidence is insufficient to recommend coconut oil or MCT oil as a treatment or preventive strategy for Alzheimer's disease or cognitive decline.

Blood Sugar and Insulin Control

Although animal studies have suggested that MCTs help lower blood sugar levels and improve insulin function (Kochikuzhyil et al., Indian J Pharmacol, 2010; Murata et al., Am J Physiol Endocrinol Metab, 2019) [27][28], human evidence tells a different story.

An analysis of 11 clinical studies that included people with or without metabolic diseases (including diabetes) consuming coconut oil (about 5 to 50 grams, or about 1/3 to 3⅔ tablespoons daily) for 3 to 28 weeks concluded that long-term intake of coconut oil did not improve blood sugar control and actually appeared to increase insulin resistance (Dhanasekara et al., Nutr Metab Cardiovasc Dis, 2022) [29].

This finding is particularly concerning because MCTs have been promoted in ketogenic diet circles as being "insulin-neutral" or even insulin-sensitizing. The clinical data suggests otherwise when coconut oil is consumed regularly in meaningful amounts. People with diabetes or those taking medications for blood sugar control should use caution or avoid using large amounts of coconut oil long-term [29].

Blood Pressure

Animal studies suggested that coconut oil consumption might lower high blood pressure (Alves et al., Appl Physiol Nutr Metab, 2015; Alves et al., Basic Clin Pharmacol Toxicol, 2017) [30][31]. However, human evidence does not support this claim.

A study in Brazil among 45 men and women (average age 41) with mild high blood pressure (average 133/89 mmHg) found that taking 10 mL (about 9.14 grams) daily of extra virgin coconut oil as capsules with meals for one month, alone or in combination with aerobic exercise training, did not decrease systolic or diastolic blood pressure compared to placebo. During the study, those taking coconut oil capsules had similar caloric and nutrient intakes as those taking placebo, with the exception of greater intakes of saturated fat, including lauric acid, from the coconut oil (Junior et al., Nutrients, 2021) [32].

Sports Performance

Several clinical trials have investigated the use of MCTs for improving high-intensity or endurance exercise performance, but the results have been inconsistent and largely disappointing [33][34].

Negative findings. In one small trial among cyclists, consuming a beverage containing a combination of carbohydrates and a high dose of MCTs (85 grams) during exercise worsened performance, most likely because it caused intestinal cramping (Jeukendrup et al., Am J Clin Nutr, 1998) [35]. Another small study found that 15 g (about 1 tablespoon) of extra virgin coconut oil plus caffeine (6 mg/kg body weight — amounting to over 400 mg) added to decaffeinated coffee ingested 60 minutes prior to a 1-mile run did not improve running times or influence perceived exertion ratings or lactate levels in thirteen recreational runners compared to a placebo (warm water). The results surprised the researchers, as caffeine alone or from coffee has generally been found to improve treadmill and endurance performance (Borba et al., Nutrients, 2019) [36].

Mixed evidence in older adults. A 3-month study in Japan in which nursing home residents were put on an exercise program (20 minutes twice weekly) suggested that adding MCTs (6 grams daily) to their diets resulted in greater increases in muscle strength and function than if given the same amount of a control oil (long-chain fatty acids) (Abe et al., Am J Clin Nutr, 2019) [37]. However, long-chain fatty acids are a poor choice as a control, as research in animals has shown that LCTs can impair exercise performance (Murray et al., Nutr Metab, 2011) [38]. Consequently, the gains achieved by the nursing home residents could have been due to exercise alone and not attributable to MCTs.

Synthesis. MCTs do not appear to enhance exercise performance in healthy adults and can worsen performance at high doses due to gastrointestinal distress. The one positive study in elderly nursing home residents used a questionable control and cannot be attributed to MCTs with confidence.

Epilepsy

The ketogenic diet has long been established as an effective treatment for drug-resistant epilepsy, and MCT supplementation has been explored as a way to modestly increase ketosis even outside a strict ketogenic diet framework.

Supplementation with MCT oil was reported to reduce seizure frequency in a 43-year-old man with drug-resistant partial epilepsy. One month after beginning supplementation with 100% MCT oil (one tablespoon taken twice daily, gradually increased to four tablespoons twice daily), seizure frequency was reduced from six per day to one seizure every four days. The MCT oil was taken after breakfast and dinner with 8 ounces of water to increase palatability. An attempt to increase the dose to five tablespoons twice daily was not tolerated due to excessive flatulence and diarrhea (Azzam et al., Case Rep Neurol Med, 2013) [39]. This is a single case report and should not be used to guide treatment decisions. Individuals with seizure disorders should consult their physician before using MCT oil and should not attempt to treat epilepsy without medical supervision.

Skin Health

Moisturizing and Atopic Dermatitis. Applied topically, virgin coconut oil has demonstrated efficacy as a skin moisturizer. A randomized double-blind controlled trial found that extra virgin coconut oil significantly lowered transepidermal water loss and increased skin surface lipids after two weeks compared to mineral oil (Agero et al., Dermatitis, 2004) [40][11].

Virgin coconut oil (5 mL applied twice daily over most of the body) was shown to reduce symptoms of atopic dermatitis (AD) by 68% in a two-month study that compared its effects to mineral oil, which led to only a 38% decrease (Evangelista et al., Int J Dermatol, 2014) [41]. In children with mild to moderate atopic dermatitis, a randomized double-blind clinical trial found that topical virgin coconut oil significantly reduced the SCORAD index (by 68.23% compared to 38.13% with mineral oil) over 8 weeks, with superior improvements in skin barrier function and hydration [42].

Virgin coconut oil (5 mL applied twice daily to affected skin) has also been shown to inhibit the growth of the bacterium Staphylococcus aureus on the skin in adults with atopic dermatitis, compared to extra virgin olive oil (Verallo-Rowell et al., Dermatitis, 2008) [43]. This antibacterial effect may contribute to its beneficial effects in AD, as S. aureus colonization is associated with disease severity.

Antimicrobial Properties and Acne. Lauric acid, a major constituent of coconut oil, has demonstrated broad-spectrum antimicrobial activity. One study in mice found that lauric acid was more effective at inhibiting Propionibacterium acnes (the bacterium that causes acne) than benzoyl peroxide (Nakatsuji et al., J Invest Dermatol, 2009) [47]. However, coconut oil is also highly comedogenic (rated 4 out of 5 on the comedogenic scale), meaning it can clog pores [48]. Therefore, despite its antibacterial properties, topical coconut oil could potentially worsen acne in some people, particularly when applied to the face.

UV Protection. Coconut oil may slightly protect against UV radiation, having an estimated SPF value between 1 and 8 (Gause et al., Int J Cosmet Sci, 2016; Kaur et al., Pharmacognosy Res, 2010) [49]. However, it should not be used as a substitute for sunscreen, as the American Academy of Dermatology recommends using a product with an SPF of 30 or higher. There do not appear to be published clinical studies on the effects of consuming coconut oil or applying it topically for anti-aging effects or for preventing or reducing wrinkles [1].

Hair Health

Preliminary studies suggest that applying coconut oil to hair can help prevent protein loss in hair strands. When used as a pre-wash conditioner, coconut oil may help prevent cuticle damage by reducing the amount of water absorbed by, and subsequent swelling of, the hair shaft during washing. It also provides lubrication when brushing (Rele et al., J Cosmet Sci, 1999; 2003) [50][51]. However, there is no scientific evidence that topical application of coconut oil promotes hair growth on the scalp or body [52].

Dandruff. A 2021 longitudinal study involving 140 participants found that twice-weekly application of virgin coconut oil for 12 weeks reduced dandruff scores, itching, and transepidermal water loss, with more sustained effects observed in healthy scalps [53]. Laboratory research has shown that MCTs prevent the growth of Malassezia species, yeast-like fungi linked with dandruff (Papavassilis et al., Crit Care Med, 1999) [54], though rigorous clinical trials specifically evaluating MCT oil for dandruff are lacking.

Oral Health

Swishing coconut oil around the mouth and in between the teeth — a process sometimes referred to as coconut oil "pulling" — has been promoted for dental health, with roots in Ayurvedic tradition.

A clinical study in India among 40 dental students (average age 21) showed that rinsing with 10 to 15 mL of coconut oil for 10 minutes per day for 7 days without brushing prevented plaque buildup better than rinsing with water. However, it is unclear if coconut oil would have similar benefit if used with normal brushing (Nagilla et al., J Clin Diagn Res, 2017) [55].

A clinical study in Turkey showed that rinsing with 10 mL of coconut oil for 15 to 20 minutes twice daily for 4 days without brushing or chewing gum reduced overall plaque buildup, gingivitis, and bleeding upon probing similar to rinsing with 10 mL of 0.2% chlorhexidine mouth rinse for just 30 seconds twice daily. However, the chlorhexidine rinse appeared to be more effective at preventing plaque buildup on the side of the teeth facing the cheek — although chlorhexidine can cause tooth staining (Sezgin et al., Complement Ther Med, 2019) [56].

A 2016 systematic review of five RCTs found that oil pulling significantly lowered plaque index scores and bacterial colony counts compared to placebo or no treatment, with effects comparable to chlorhexidine in some measures [57]. Oil pulling should be considered a potential adjunct to, not a replacement for, standard dental hygiene practices. It is contraindicated in children under 5 due to aspiration risk [57].

Fat Malabsorption

There is preliminary evidence that supplementation with MCTs may be helpful for individuals with conditions that interfere with the body's ability to absorb fat, such as AIDS-related fat malabsorption, pancreatitis, short bowel syndrome, and pancreatic insufficiency [1][3]. Because MCTs are absorbed directly into the portal circulation without requiring bile salts or chylomicron formation, they can provide calories and essential fatty acids to patients who cannot adequately absorb conventional dietary fats.

Coronary Artery Disease (Rare Condition)

A specific MCT called tricaprin (also known as glycerol tridecanoate or tridecanoin) has been investigated for treating a very rare type of coronary artery disease called triglyceride deposit cardiomyovasculopathy (TGCV). While preliminary research showed that tricaprin improved the breakdown of fats by heart muscle cells in people with this condition, it did not appear to improve the severity of symptoms, the extent of heart failure, or other clinically relevant outcomes compared to placebo [1].

Recommended Dosing

Oral Dosing by Indication

Indication	Form	Dose	Duration	Evidence Level
Weight management	MCT oil (C8/C10)	5+ grams daily	3+ months	Moderate (one positive RCT)
Cognitive support (MCI)	MCT oil (C8/C10)	30 grams daily (titrate up over 2 weeks)	6 months	Limited (one positive two-phase study)
Alzheimer's disease	MCT oil (C8/C10)	20–40 grams daily	4–6 months	Weak (mixed results, negative studies)
Epilepsy (adjunct)	100% MCT oil	1–4 tablespoons twice daily	Ongoing	Very limited (single case report)
Ketogenic diet support	MCT oil or refined coconut oil	15–30 grams daily	Ongoing	Moderate (consistent ketone elevation)

Gradual dose escalation. For any oral MCT supplementation, it is important to gradually increase the dose over 1–2 weeks to minimize gastrointestinal side effects. Most clinical studies that used higher doses (20–30 g/day) incorporated a titration period, and even then, side effects were common [14][19][20].

Topical Dosing

Indication	Form	Dose	Frequency
Atopic dermatitis	Virgin coconut oil	5 mL (1 teaspoon)	Twice daily to affected areas
General moisturizing	Virgin coconut oil	As needed	Once or twice daily
Hair conditioning (pre-wash)	Coconut oil (any type)	Sufficient to coat hair	Before washing, leave 15–30 minutes
Hair conditioning (post-wash)	Coconut oil	Small amount	After washing, to damp hair

Cooking and Storage

Coconut oil has a relatively low smoke point of 350°F (177°C) for virgin oil compared to other common cooking oils such as extra virgin olive oil (383°F), safflower (413°F), and canola (460°F). Refined coconut oil has a higher smoke point of 400–450°F (204–232°C) [12][13]. Virgin coconut oil's low smoke point makes it less suitable for frying, but it can be used for cooking and baking at temperatures below 350°F.

Coconut oil has a high saturated fat content, so daily intake should be considered in the context of overall saturated fat consumption (the AHA recommends limiting to 5–6% of total calories, approximately 13 grams/day) [7][9]. The saturated fats make both coconut oil and MCT oil very stable, so they do not require refrigeration — although refrigeration will give virgin coconut oil a harder consistency [1].

How to Choose a Product

For products marketed as MCT oil, the label should list "Total MCTs," which should be at least 85% of the serving — for example, a 14-gram serving should provide at least 12 grams (12,000 mg) of MCTs [1]. If you specifically want the fast-acting MCTs (caprylic and capric acids rather than lauric acid), make sure the amounts of C8 and/or C10 are listed on the label and comprise 95–100% of the total oil [1].

Virgin coconut oil is appropriate for topical uses (skin and hair) and low-heat cooking, but would not be the right choice if you are looking for a product high in caprylic and capric acids for cognitive or ketogenic purposes [1].

Safety and Side Effects

Gastrointestinal Effects

The most common side effects of coconut oil and MCT oil are gastrointestinal in nature. Coconut oil may cause diarrhea, loose stools, stomach ache, nausea, and vomiting in some individuals. These effects are more likely to occur within the first week of consumption and when the oil is consumed on an empty stomach (Chinwong et al., Evid Based Complement Alternat Med, 2017) [60]. Diarrhea, vomiting, bloating, and cramps can also occur when supplementing with MCT oil, particularly at higher doses (Azzam et al., Case Rep Neurol Med, 2013; Liu et al., Biomed J, 2013) [39][61].

In the Canadian Alzheimer's study, 64% of participants taking MCT oil reported side effects including vomiting, diarrhea, and abdominal cramping, particularly at the maximum daily dose of 3 tablespoons [14]. Gradual dose escalation over 1–2 weeks and taking MCT oil with food can help minimize these effects.

Cardiovascular Concerns — Cholesterol Effects

This is the most significant safety concern associated with coconut oil consumption. Most of the fat in coconut oil (82–92%) is saturated fat, and this percentage approaches 100% in pure MCT oil [7][8].

AHA position. The American Heart Association advises against use of coconut oil because it can increase LDL ("bad") cholesterol with, in the opinion of the AHA, no favorable offsetting effects (Sacks et al., Circulation, 2017) [9].

Meta-analysis evidence. A review of 16 clinical trials that compared coconut oil to nontropical vegetable oils (e.g., soybean, olive, safflower, or canola oil) found use of coconut oil to be associated with an average increase of 14.69 mg/dL in total cholesterol and 10.47 mg/dL in LDL cholesterol, although it was also associated with a small increase (4 mg/dL) in HDL ("good") cholesterol (Neelakantan et al., Circulation, 2020) [7].

The HDL increase may not be clinically meaningful. Although high HDL levels are associated with lower cardiovascular risk, interventions to raise HDL — such as with high-dose niacin or fibrates — have not been shown to reduce cardiovascular risk in clinical outcomes trials (Abbasi, JAMA, 2020) [62]. Therefore, the small HDL increase from coconut oil should not be considered a meaningful cardiovascular benefit.

WHO position. A 2024 WHO rapid overview of systematic reviews on coconut oil compared to other vegetable oils found evidence of adverse effects on lipid parameters associated with cardiometabolic health, though overall mortality and CVD event data remain limited [63].

Dissenting evidence. Not all studies have found coconut oil to have negative effects on cholesterol levels in healthy individuals. A study in Thailand among healthy young adults (average age 21) found that 15 mL of virgin coconut oil taken twice daily for two months increased HDL cholesterol by 5.72 mg/dL but did not significantly increase total cholesterol, LDL cholesterol, or triglyceride levels compared to a control (Chinwong et al., Evid Based Complement Alternat Med, 2017) [60]. A 2025 review of 26 studies suggested that recommendations to avoid coconut oil due to heart disease risk may not be fully justified when considering lipid parameters beyond total and LDL cholesterol [64].

Interaction with Statin Therapy

Taking coconut oil along with statins may lessen the cholesterol-lowering effects of statin therapy. A study in India among 150 people with high cholesterol or triglycerides who were started on atorvastatin (10 mg/day) and given 1,000 mg per day of virgin coconut oil or placebo for 8 weeks showed that coconut oil resulted in smaller reductions in LDL cholesterol (−16.37 vs. −19.62 mg/dL) and total cholesterol (−6.51 vs. −19.92 mg/dL). While HDL cholesterol increased slightly more in the coconut oil group (+3.96 vs. +1.20 mg/dL), this is of less clinical significance than the attenuated LDL reductions (Maiti et al., J Am Nutr Assoc, 2023) [66].

Insulin Resistance

When used daily in large amounts (up to about 3⅔ tablespoons daily), coconut oil might worsen insulin resistance [29]. People with diabetes or those taking medications for blood sugar control should use caution or avoid using large amounts of coconut oil long-term.

Allergic Reactions

Allergic and anaphylactic reactions can occur from eating coconut fruit (i.e., coconut meat), but this is unlikely to occur with refined coconut oil, as coconut proteins (which can trigger allergic reactions) are removed during the oil extraction process [67]. Skin reactions such as rash and hives have been reported after topical use of coconut oil (Anagnostou et al., Children (Basel), 2017) [68]. Individuals with tree nut allergies may experience cross-reactivity due to shared protein structures, though coconut is botanically distinct from true nuts [68].

Special Populations

Children. Coconut oil is possibly safe when applied topically to the skin for short periods, such as approximately one month. However, there is insufficient reliable information to determine the safety of coconut oil when taken by mouth as a medicine in children. Oil pulling is contraindicated in children under 5 due to aspiration risk [57].

Liver disease. For individuals with liver impairment, MCTs can overload hepatic processing, potentially exacerbating damage. MCTs should be used cautiously in this population.

Comedogenic risk. When applied topically to facial skin, coconut oil is highly comedogenic (rated 4 out of 5) and can clog pores, potentially causing or exacerbating acne in acne-prone individuals [48].

Drug Interactions

Coconut oil has relatively few well-documented drug interactions, but several clinically relevant interactions should be noted.

Drug / Drug Class	Interaction	Clinical Significance	Management
Statins (e.g., atorvastatin)	Coconut oil may reduce the cholesterol-lowering effect of statins by raising LDL cholesterol independently	Moderate — resulted in a 3.25 mg/dL smaller LDL reduction and a 13.41 mg/dL smaller total cholesterol reduction over 8 weeks	Avoid concurrent use of large amounts of coconut oil with statins; if using coconut oil, monitor lipid panel [66]
Diabetes medications (insulin, metformin, sulfonylureas, etc.)	Large amounts of coconut oil may worsen insulin resistance, potentially counteracting glucose-lowering medications	Moderate — based on meta-analysis of 11 studies showing increased insulin resistance	Avoid large amounts of coconut oil long-term if taking diabetes medications; monitor blood glucose [29]
Blood thinners / anticoagulants	Theoretical — coconut oil may affect platelet function	Low — no well-documented clinical interactions	Monitor if consuming large amounts
Antihypertensives	No evidence of interaction; coconut oil did not affect blood pressure in clinical trial	Low	No specific management needed [32]

Because MCTs are rapidly metabolized by the liver, they theoretically could affect the metabolism of drugs processed by the same hepatic pathways. However, no specific cytochrome P450 interactions have been documented for MCTs or coconut oil.

Dietary Sources

Coconut-Based Sources

Source	MCT Content	Notes
Virgin coconut oil	~62% total MCTs (mostly lauric acid); ~10–15% C8+C10	1 tbsp (14 g) provides ~8.7 g total MCTs, but only ~1.4–2.1 g of rapidly-metabolized C8+C10
Coconut meat (fresh)	~33% fat by weight, of which ~62% are MCTs	Approximately 3 g total MCTs per ounce of fresh coconut meat
Coconut milk (canned)	~17–24% fat, depending on dilution	Variable MCT content depending on dilution with water
Coconut cream	~24–34% fat	Higher MCT content than coconut milk
Desiccated coconut	~65% fat by weight	Similar fatty acid profile to coconut oil

Other Dietary Sources of MCTs

Source	Notable MCTs	Content
Palm kernel oil	Lauric acid (C12) primarily	~50% MCTs (similar to coconut oil)
Dairy fat (butter, cheese, whole milk)	Small amounts of C6, C8, C10	~10–15% of dairy fat is MCTs, mostly short-chain (C4–C6)
Human breast milk	Lauric acid, capric acid	~10–12% of fatty acids are MCTs
Goat milk	Capric acid (C10), caprylic acid (C8)	Slightly higher MCT content than cow's milk
Babassu oil	Lauric acid (C12)	~40–45% MCTs; used regionally in Brazil

Nutritional Profile of Coconut Oil

One tablespoon (14 g) of coconut oil provides approximately [8]:

• 120 calories
• 14 g total fat (all from fat)
• ~11.5 g saturated fat (88% of calories)
• ~0.8 g monounsaturated fat
• ~0.2 g polyunsaturated fat
• 0 g protein, 0 g carbohydrates, 0 g fiber
• Trace amounts of vitamin E (0.01 mg)
• No significant vitamins or minerals

Fatty Acid Composition of Coconut Oil

Fatty Acid	Carbon Length	Type	Percentage
Lauric acid	C12:0	Saturated (medium-chain)	45–52%
Myristic acid	C14:0	Saturated (long-chain)	16–21%
Palmitic acid	C16:0	Saturated (long-chain)	7–10%
Caprylic acid	C8:0	Saturated (medium-chain)	5–8%
Capric acid	C10:0	Saturated (medium-chain)	5–7%
Oleic acid	C18:1	Monounsaturated	5–10%
Stearic acid	C18:0	Saturated (long-chain)	2–4%
Linoleic acid	C18:2	Polyunsaturated	1–2%
Caproic acid	C6:0	Saturated (short-chain)	<1%

References

1. ConsumerLab. "Coconut and MCT Oil Review." Accessed 2025. https://www.consumerlab.com/reviews/coconut-and-mct-oils/coconut-mct-oil/

2. Grokipedia. "Coconut oil." https://grokipedia.com/page/Coconut_oil

3. Clegg ME. "They say coconut oil can aid weight loss, but can it really?" Eur J Clin Nutr. 2017;71(10):1139-1143. https://doi.org/10.1038/ejcn.2017.86

4. Fortier M et al. "A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment." Alzheimers Dement. 2019;15(5):625-634. https://doi.org/10.1016/j.jalz.2018.12.017

5. Henderson ST et al. "Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease." Nutr Metab (Lond). 2009;6:31. https://doi.org/10.1186/1743-7075-6-31

6. Bach AC, Babayan VK. "Medium-chain triglycerides: an update." Am J Clin Nutr. 1982;36(5):950-962. https://doi.org/10.1093/ajcn/36.5.950

7. Neelakantan N et al. "The Effect of Coconut Oil Consumption on Cardiovascular Risk Factors." Circulation. 2020;141(10):803-814. https://doi.org/10.1161/CIRCULATIONAHA.119.043052

8. U.S. Department of Agriculture, FoodData Central. "Oil, coconut." https://fdc.nal.usda.gov/

9. Sacks FM et al. "Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association." Circulation. 2017;136(3):e1-e23. https://doi.org/10.1161/CIR.0000000000000510

10. Marina AM et al. "Chemical Properties of Virgin Coconut Oil." J Am Oil Chem Soc. 2009;86:301-307. https://doi.org/10.1007/s11746-009-1351-1

11. Agero AL, Verallo-Rowell VM. "A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis." Dermatitis. 2004;15(3):109-116. https://pubmed.ncbi.nlm.nih.gov/15724344/

12. Dayrit FM. "The Properties of Lauric Acid and Their Significance in Coconut Oil." J Am Oil Chem Soc. 2015;92:1-15. https://doi.org/10.1007/s11746-014-2562-7

13. Katragadda HR et al. "Emissions of volatile aldehydes from heated cooking oils." Food Chem. 2010;120(1):59-65. https://doi.org/10.1016/j.foodchem.2009.09.070

14. Juby AG et al. "Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease." Alzheimers Dement (N Y). 2022;8(1):e12259. https://doi.org/10.1002/trc2.12259

15. Nosaka N et al. "Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans." J Atheroscler Thromb. 2003;10(5):290-298. https://doi.org/10.5551/jat.10.290

16. Vogel CL et al. "Effect of coconut oil on weight loss and metabolic parameters in men with obesity." Food Funct. 2020;11(7):6588-6594. https://doi.org/10.1039/D0FO00872A

17. Diekmann C et al. "Coconut oil versus canola oil on appetite and satiety in overweight older adults." J Nutr. 2025.

18. Systematic review and meta-analysis of coconut oil supplementation on body weight. 2025.

19. Fortier M et al. "A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment." Alzheimers Dement. 2019;15(5):625-634. https://doi.org/10.1016/j.jalz.2018.12.017

20. Fortier M et al. "A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT." Alzheimers Dement. 2020;17(3):543-552. https://doi.org/10.1002/alz.12206

21. Roy M et al. "MCT supplementation improves white matter energy supply in mild cognitive impairment." medRxiv. 2021 (preprint).

22. Henderson ST et al. "Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease." Nutr Metab (Lond). 2009;6:31. https://doi.org/10.1186/1743-7075-6-31

23. Reger MA et al. "Effects of beta-hydroxybutyrate on cognition in memory-impaired adults." Neurobiol Aging. 2004;25(3):311-314. https://doi.org/10.1016/S0197-4580(03)00087-3

24. Fernando WM et al. "The role of dietary coconut for the prevention and treatment of Alzheimer's disease." Br J Nutr. 2015;114(1):1-14. https://doi.org/10.1017/S0007114515001452

25. Fernando WM et al. "A randomized, double-blind, placebo-controlled trial of coconut oil for Alzheimer's disease." J Alzheimers Dis. 2023;93(4):1279-1289. https://doi.org/10.3233/JAD-220953

26. Pinto A et al. "Impact of Coconut Oil and Its Bioactive Metabolites in Alzheimer's Disease." Crit Rev Food Sci Nutr. 2024. https://doi.org/10.1080/10408398.2023.2186710

27. Kochikuzhyil BM et al. "Effect of saturated fatty acid-rich dietary vegetable oils on lipid profile in diabetic rats." Indian J Pharmacol. 2010;42(3):142-145. https://doi.org/10.4103/0253-7613.66835

28. Murata Y et al. "Medium-chain triglyceride diet improves insulin sensitivity and glucose tolerance." Am J Physiol Endocrinol Metab. 2019.

29. Dhanasekara CS et al. "Coconut oil intake and its effects on metabolic parameters." Nutr Metab Cardiovasc Dis. 2022;32(9):2097-2106. https://doi.org/10.1016/j.numecd.2022.06.004

30. Alves NF et al. "Coconut oil supplementation and physical exercise improves baroreflex sensitivity in hypertensive rats." Appl Physiol Nutr Metab. 2015;40(4):393-400. https://doi.org/10.1139/apnm-2014-0351

31. Alves NF et al. "Virgin coconut oil supplementation reduces blood pressure in hypertensive rats." Basic Clin Pharmacol Toxicol. 2017.

32. Junior AHM et al. "Effects of extra virgin coconut oil on blood pressure in hypertensive individuals." Nutrients. 2021;13(11):3859. https://doi.org/10.3390/nu13113859

33. Van Zyl CG et al. "Effects of medium-chain triglyceride ingestion on fuel metabolism and cycling performance." J Appl Physiol (1985). 1996;80(6):2217-2225. https://doi.org/10.1152/jappl.1996.80.6.2217

34. Misell LM et al. "Chronic medium-chain triacylglycerol consumption and endurance performance in trained runners." J Sports Med Phys Fitness. 2001;41(2):210-215. https://pubmed.ncbi.nlm.nih.gov/11447365/

35. Jeukendrup AE et al. "Effect of medium-chain triacylglycerol and carbohydrate ingestion during exercise on substrate utilization." Am J Clin Nutr. 1998;67(3):397-404. https://doi.org/10.1093/ajcn/67.3.397

36. Borba VV et al. "Effects of extra virgin coconut oil and caffeine on exercise performance." Nutrients. 2019;11(12):2886. https://doi.org/10.3390/nu11122886

37. Abe S et al. "Medium-chain triglycerides in combination with leucine and vitamin D increase muscle strength and function in frail elderly adults." Am J Clin Nutr. 2019;110(4):831-839. https://doi.org/10.1093/ajcn/nqz131

38. Murray AJ et al. "Dietary long-chain, but not medium-chain, triglycerides impair exercise performance in the rat." Nutr Metab. 2011;8:11. https://doi.org/10.1186/1743-7075-8-11

39. Azzam R, Azar NJ. "Marked seizure reduction after MCT supplementation." Case Rep Neurol Med. 2013;2013:809151. https://doi.org/10.1155/2013/809151

40. Agero AL, Verallo-Rowell VM. "A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer." Dermatitis. 2004;15(3):109-116. https://pubmed.ncbi.nlm.nih.gov/15724344/

41. Evangelista MT et al. "The effect of topical virgin coconut oil on SCORAD index in mild to moderate pediatric atopic dermatitis." Int J Dermatol. 2014;53(1):100-108. https://doi.org/10.1111/ijd.12339

42. Evangelista MT et al. "Topical virgin coconut oil in mild to moderate pediatric atopic dermatitis." Int J Dermatol. 2014.

43. Verallo-Rowell VM et al. "Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis." Dermatitis. 2008;19(6):308-315. https://pubmed.ncbi.nlm.nih.gov/19134433/

44. Topical application of coconut oil to the skin of preterm infants: systematic review.

45. Lieberman S et al. "A Review of Monolaurin and Lauric Acid: Natural Virucidal and Bactericidal Agents." Alternative and Complementary Therapies. 2006;12(6):310-314. https://doi.org/10.1089/act.2006.12.310

46. Dayrit FM. "The Properties of Lauric Acid and Their Significance in Coconut Oil." J Am Oil Chem Soc. 2015;92:1-15. https://doi.org/10.1007/s11746-014-2562-7

47. Nakatsuji T et al. "Antimicrobial property of lauric acid against Propionibacterium acnes." J Invest Dermatol. 2009;129(10):2480-2488. https://doi.org/10.1038/jid.2009.93

48. Fulton JE Jr. "Comedogenicity and irritancy of commonly used ingredients in skin care products." J Soc Cosmet Chem. 1989;40:321-333.

49. Gause S, Chauhan A. "UV-blocking potential of oils and juices." Int J Cosmet Sci. 2016;38(4):354-360. https://doi.org/10.1111/ics.12296; Kaur CD, Saraf S. "In vitro sun protection factor determination of herbal oils." Pharmacognosy Res. 2010;2(1):22-25. https://doi.org/10.4103/0974-8490.60586

50. Rele AS, Mohile RB. "Effect of mineral oil, sunflower oil, and coconut oil on prevention of hair damage." J Cosmet Sci. 1999;50:169-184.

51. Rele AS, Mohile RB. "Effect of coconut oil on prevention of hair damage. Part II." J Cosmet Sci. 2003;54(2):175-192. https://pubmed.ncbi.nlm.nih.gov/12715094/

52. Grokipedia. "Coconut oil — Hair health." https://grokipedia.com/page/Coconut_oil

53. Lu LJ et al. "Effect of virgin coconut oil application on the skin microbiota in dandruff." Longitudinal study, 2021.

54. Papavassilis C et al. "Antifungal properties of medium-chain triglycerides against Malassezia species." Crit Care Med. 1999.

55. Nagilla J et al. "Comparative evaluation of coconut oil pulling and sesame oil pulling on oral health status." J Clin Diagn Res. 2017;11(6):ZC08-ZC11. https://doi.org/10.7860/JCDR/2017/25833.9997

56. Sezgin Y et al. "Efficacy of oil pulling therapy with coconut oil on four-day supragingival plaque growth." Complement Ther Med. 2019;47:102220. https://doi.org/10.1016/j.ctim.2019.102220

57. Peedikayil FC et al. "Effect of coconut oil in plaque related gingivitis." Niger Med J. 2015;56(2):143-147. https://doi.org/10.4103/0300-1652.153406; Systematic review of 5 RCTs on oil pulling, 2016.

58. Pilot study on virgin coconut oil as ocular rewetting agent. Evid Based Complement Alternat Med. 2015.

59. Coconut oil as butter substitute in vegan baking.

60. Chinwong S et al. "Daily consumption of virgin coconut oil increases high-density lipoprotein cholesterol levels in healthy volunteers." Evid Based Complement Alternat Med. 2017;2017:7251562. https://doi.org/10.1155/2017/7251562

61. Liu YM, Wang HS. "Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy." Biomed J. 2013;36(1):9-15. https://doi.org/10.4103/2319-4170.107154

62. Abbasi J. "Raising HDL Cholesterol Not a Sure Way to Reduce Cardiovascular Risk." JAMA. 2020;323(2):109-110. https://doi.org/10.1001/jama.2019.20044

63. World Health Organization. "Rapid overview of systematic reviews on coconut oil." 2024. https://www.who.int/publications/i/item/9789240088368

64. Coconut Coalition analysis of 26 studies on lipid parameters. 2025. https://coconutcoalition.org/analysis-of-26-studies-of-the-impact-of-coconut-oil-on-lipid-parameters-beyond-total-and-ldl-cholesterol/

65. Systematic review of randomized trials on coconut oil vs alternatives. 2022.

66. Maiti S et al. "Effect of virgin coconut oil supplementation on atorvastatin-treated dyslipidemia patients." J Am Nutr Assoc. 2023;42(7):653-659. https://doi.org/10.1080/07315724.2022.2123529

67. Gomez Torrijos E et al. "Coconut allergy: clinical and immunological characterization." Allergol Immunopathol (Madr). 2019.

68. Anagnostou K. "Coconut allergy revisited." Children (Basel). 2017;4(10):85. https://doi.org/10.3390/children4100085

69. Case report of hepatic steatosis in infant on coconut milk formula.